COYA Coya Therapeutics, Inc.: institutional ownership and insider trading
56 funds reported holding $51.0M of Coya Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net sold $1.97M, with 5 new positions and 6 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Famous investors holding COYA
- David Einhorn (Greenlight Capital): $13.7M, 0.4% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $1.13M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $76.7K, 0.0% of the portfolio
Largest institutional holders of COYA
- DME Capital Management, LP — $13.7M
- VANGUARD GROUP INC — $5.22M
- VANGUARD CAPITAL MANAGEMENT LLC — $4.93M
- Alyeska Investment Group, L.P. — $4.68M
- AIGH Capital Management LLC — $3.70M
- CM Management, LLC — $2.34M
- PRIVATE MANAGEMENT GROUP INC — $2.25M
- MARSHALL WACE, LLP — $1.46M
- GEODE CAPITAL MANAGEMENT, LLC — $1.34M
- RENAISSANCE TECHNOLOGIES LLC — $1.13M
Recent COYA insider trades
- Nov 14, 2024: Snyder David S bought 1,800 shares ($12.9K)
- Nov 13, 2024: Swaminathan Arun bought 5,000 shares ($36.8K)
- Nov 11, 2024: Grossman Fred bought 2,710 shares ($20.0K)
- Nov 11, 2024: Swaminathan Arun bought 5,000 shares ($36.7K)
5%+ owners
- DME Advisors GP, L.L.C.: 9.9% (Schedule 13G/A, filed Feb 14, 2025)
- Dr. Reddy's Laboratories, Inc.: 9.7% (Schedule 13G, filed Mar 12, 2026)